Biogen Drops After Alzheimer’s Drug Trial Change Raises Concerns – Bloomberg

February 14, 2018 by  
Filed under Alzheimers News

Sponsored By

Bloomberg
Biogen Drops After Alzheimer's Drug Trial Change Raises Concerns
Bloomberg
Biogen Inc. plunged after the company said it was making changes to a trial of an Alzheimer's disease drug, after a long list of rival drugs failed. In a presentation to investors Wednesday, Biogen said it would add about 500 more patients to its
Biogen's share price falters on a surprise dose of 'variability' in Alzheimer's trialSTAT
Biogen shares fall as it adds patients to Alzheimer's medicine trialsFinancial Times

all 3 news articles »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*